This study mainly reveals that ALM attenuates oxidative stress and inflammation levels through activation of the PI3K/Akt signaling pathway, thus achieving therapeutic effects in reducing myocardial hypertrophy, revealing the potential of ALM as a drug candidate for the treatment of myocardial hypertrophy characterized by oxidative stress and inflammation. Here, AKT1 is linked to cardiac hypertrophy.